FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2101283545> ?p ?o ?g. }

• W2101283545 endingPage "1598" @default.
• W2101283545 startingPage "1589" @default.
• W2101283545 abstract "In previous studies we identified a surface molecule (termed GL183) capable of mediating cell activation and selectively expressed by a subset of human CD3-CD16+ natural killer (NK) cells. In this study we analyzed whether other subset-specific functional molecules were expressed in GL183- NK cells. To this end, mice were immunized with the PE29 (CD3-CD16+GL183-) NK clone. Monoclonal antibodies (mAbs) were selected by screening the hybridoma supernatants for their ability to trigger the cytolytic activity of clone PE29 against the human myelomonocytic leukemia U937. The EB6 mAb (IgG1) triggered the PE29 clone, but not a GL183+ clone used as a control. EB6+ cells ranged between 1 and 13% of peripheral blood lymphocytes and were largely included in the CD3-CD16+CD56+ cell populations (only less than 2% of EB6+ cells were CD3+). Analysis of resting or activated CD3-CD16+ populations, or clones for the expression of EB6 or GL183 mAbs, allowed us to identify four distinct, phenotypically stable, NK subsets (EB6+GL183-; EB6+GL183+; EB6-GL183+; EB6-GL183-). Similar to GL183 mAb, the EB6 mAb selectively triggered the NK subset expressing the corresponding surface antigen to lyse human tumor cell lines including U937, IGROV-I, M14, and A549. In addition, EB6 mAb sharply inhibited the cytolytic activity of EB6+ clones against P815, M12, and P3U1 murine target cells. In EB6+GL183+ (double-positive) clones both EB6 and GL183 mAb inhibited the redirected killing of P815 cells induced by anti-CD16, anti-CD2 mAbs and phytohemagglutinin (PHA). Similar to GL183 molecules, molecules precipitated by EB6 mAb were represented by either single 58-kD chain or double chains of 55 and 58 kD (with no detectable differences in EB6+GL183- or EB6+GL183+ clones). In sequential immunoprecipitation experiments using the double-positive clones CEG52 and CA25.50, preclearing of cell lysates with EB6 or GL183 mAb removed only EB6 or GL183 molecules, respectively, thus indicating that the two antigenic determinants are carried by two distinct molecules. Peptide map analysis indicated that EB6 (or GL183) molecules precipitated from double-positive clones were identical to the corresponding molecules isolated from single-positive ones. On the other hand, comparison of the EB6 and GL183 maps revealed peptides that were unique to each molecule, although most of the major peptides migrated to identical positions. We further investigated whether correlation existed between the phenotypic assignment of NK clones and their ability to mediate specific lysis of normal allogeneic cells.(ABSTRACT TRUNCATED AT 400 WORDS)" @default.
• W2101283545 created "2016-06-24" @default.
• W2101283545 creator A5003370028 @default.
• W2101283545 creator A5003405783 @default.
• W2101283545 creator A5005421175 @default.
• W2101283545 creator A5011815731 @default.
• W2101283545 creator A5020843731 @default.
• W2101283545 creator A5035849763 @default.
• W2101283545 creator A5048640766 @default.
• W2101283545 creator A5071526274 @default.
• W2101283545 creator A5078129526 @default.
• W2101283545 creator A5012764134 @default.
• W2101283545 date "1990-12-01" @default.
• W2101283545 modified "2023-10-16" @default.
• W2101283545 title "Identification of four subsets of human CD3-CD16+ natural killer (NK) cells by the expression of clonally distributed functional surface molecules: correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition." @default.
• W2101283545 cites W1484857073 @default.
• W2101283545 cites W1556867369 @default.
• W2101283545 cites W1584268075 @default.
• W2101283545 cites W1979560589 @default.
• W2101283545 cites W1986656701 @default.
• W2101283545 cites W2003870859 @default.
• W2101283545 cites W2013416826 @default.
• W2101283545 cites W2018289835 @default.
• W2101283545 cites W2022611929 @default.
• W2101283545 cites W2036275492 @default.
• W2101283545 cites W2046464172 @default.
• W2101283545 cites W2057073801 @default.
• W2101283545 cites W2062964622 @default.
• W2101283545 cites W2063290750 @default.
• W2101283545 cites W2068939227 @default.
• W2101283545 cites W2070335288 @default.
• W2101283545 cites W2083836029 @default.
• W2101283545 cites W2092968163 @default.
• W2101283545 cites W2100837269 @default.
• W2101283545 cites W2107359414 @default.
• W2101283545 cites W2127022844 @default.
• W2101283545 cites W2132853354 @default.
• W2101283545 cites W2136488457 @default.
• W2101283545 cites W2140763432 @default.
• W2101283545 cites W2154019156 @default.
• W2101283545 cites W2165279245 @default.
• W2101283545 doi "https://doi.org/10.1084/jem.172.6.1589" @default.
• W2101283545 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2188758" @default.
• W2101283545 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2147946" @default.
• W2101283545 hasPublicationYear "1990" @default.
• W2101283545 type Work @default.
• W2101283545 sameAs 2101283545 @default.
• W2101283545 citedByCount "372" @default.
• W2101283545 countsByYear W21012835452012 @default.
• W2101283545 countsByYear W21012835452013 @default.
• W2101283545 countsByYear W21012835452014 @default.
• W2101283545 countsByYear W21012835452015 @default.
• W2101283545 countsByYear W21012835452016 @default.
• W2101283545 countsByYear W21012835452017 @default.
• W2101283545 countsByYear W21012835452018 @default.
• W2101283545 countsByYear W21012835452019 @default.
• W2101283545 countsByYear W21012835452020 @default.
• W2101283545 countsByYear W21012835452021 @default.
• W2101283545 countsByYear W21012835452022 @default.
• W2101283545 countsByYear W21012835452023 @default.
• W2101283545 crossrefType "journal-article" @default.
• W2101283545 hasAuthorship W2101283545A5003370028 @default.
• W2101283545 hasAuthorship W2101283545A5003405783 @default.
• W2101283545 hasAuthorship W2101283545A5005421175 @default.
• W2101283545 hasAuthorship W2101283545A5011815731 @default.
• W2101283545 hasAuthorship W2101283545A5012764134 @default.
• W2101283545 hasAuthorship W2101283545A5020843731 @default.
• W2101283545 hasAuthorship W2101283545A5035849763 @default.
• W2101283545 hasAuthorship W2101283545A5048640766 @default.
• W2101283545 hasAuthorship W2101283545A5071526274 @default.
• W2101283545 hasAuthorship W2101283545A5078129526 @default.
• W2101283545 hasBestOaLocation W21012835451 @default.
• W2101283545 hasConcept C104317684 @default.
• W2101283545 hasConcept C114684123 @default.
• W2101283545 hasConcept C147483822 @default.
• W2101283545 hasConcept C153911025 @default.
• W2101283545 hasConcept C154317977 @default.
• W2101283545 hasConcept C159654299 @default.
• W2101283545 hasConcept C167672396 @default.
• W2101283545 hasConcept C202751555 @default.
• W2101283545 hasConcept C203014093 @default.
• W2101283545 hasConcept C2778102761 @default.
• W2101283545 hasConcept C2781462264 @default.
• W2101283545 hasConcept C542903549 @default.
• W2101283545 hasConcept C55493867 @default.
• W2101283545 hasConcept C73588182 @default.
• W2101283545 hasConcept C81089528 @default.
• W2101283545 hasConcept C86803240 @default.
• W2101283545 hasConceptScore W2101283545C104317684 @default.
• W2101283545 hasConceptScore W2101283545C114684123 @default.
• W2101283545 hasConceptScore W2101283545C147483822 @default.
• W2101283545 hasConceptScore W2101283545C153911025 @default.
• W2101283545 hasConceptScore W2101283545C154317977 @default.
• W2101283545 hasConceptScore W2101283545C159654299 @default.
• W2101283545 hasConceptScore W2101283545C167672396 @default.
• W2101283545 hasConceptScore W2101283545C202751555 @default.
• W2101283545 hasConceptScore W2101283545C203014093 @default.
• W2101283545 hasConceptScore W2101283545C2778102761 @default.

• next